Rufinamide
| Catalog No. | KMR090001 |
|---|---|
| CAS No. | 106308-44-5 |
| Formula | C10H8F2N4O |
| FW | 238.0 |
| Unit | Price | Stock |
|---|---|---|
| 100 mg | Enquire | Enquire |
| Chemical Name: | 1-[(2,6-Difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide |
|---|---|
| Purity: | >95% |
| Storage: | Store at 2-8 deg. C for long term storage |
| Shipping: | Product is stable to be Shipped at Room Temperature |
Rufinamide is chemically 1-[(2,6-Difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide .
Rufinamide is supplied with detailed characterization data compliant with regulatory guideline.
Rufinamide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC)
application for Abbreviated New Drug Application (ANDA) or during commercial production of Rufinamide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
Related Products
CAT No: KMR090003
CAT No: KMR090012
Rufinamide USP Related Compound B
CAS No.: 217448-86-7
CAT No.: KMR090012
Formula : C11H9F2N3O2
FW : 253.2
CAT No: KMR090002
Rufinamide 2,6-Didesfluoro Impurity
CAS No.: 80819-65-4
CAT No.: KMR090002
Formula : C10H10N4O
FW : 202.2
CAT No: KMR090004
CAT No: KMR090006
CAT No: KMR090007
CAT No: KMR090008
CAT No: KMR090009
CAT No: KMR090010
CAT No: KMR090011
Rufinamide USP Related Compound A
CAS No.: 106308-41-2
CAT No.: KMR090011
Formula : C10H9FN4O
FW : 220.2
CAT No: KMR090014
CAT No: KMR090013
Rufinamide USP Related Compound B-D3
CAS No.: NA
CAT No.: KMR090013
Formula : C11H6D3F2N3O2
FW : 256.2
CAT No: KMR090005
Rufinamide D2 Metabolite
CAS No.: 1346597-78-1
CAT No.: KMR090005
Formula : C11H7D2F2N3O2
FW : 255.2